In October, DeLauro asked the FDA to provide an update within the week on the status of the development of the breast density notification rule. The FDA’s response arrived shortly after, acknowledging that the Mammography Quality Standards Act (MQSA) final rule would publish before the end of the 2022 calendar year or early 2023.
DeLauro and Fitzpatrick previously worked together on the Breast Density and Mammography Reporting Act that directs the Food and Drug Administration (FDA) to issue a nationwide reporting standard to require all mammography reports to include an assessment of breast density. This policy change was included in the Fiscal Year 2020 Consolidated Appropriations Act and is expected to be released by the end of this year or early next year.Back to HCB News
Ad Statistics Times Displayed: 112553
Times Visited: 1587
For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.